Researchers have found a new cannabinoid from cannabis that has far more potency than tetrahydrocannabinol (THC), the popular psychoactive substance in cannabis which causes a “high.”
Tetrahydrocannabiphorol (THCP) was found in a lab test to be 30-times more likely to bind to an endocannabinoid system receptor in humans than THC, the study, published in the journal Nature, reported.
The “biological results obtained in the in vitro binding assay indicated an affinity for CB1 receptor more than thirty-fold higher compared to the one reported for Δ9-THC in the literature,” the study wrote.
The endocannabinoid system is involved in a variety of human processes including appetite, mood, memory and pain sensation. Cannabinoid receptors, which are part of the endocannabinoid system, are located throughout the human body.
Numerous clinical trials provide evidence of the therapeutic potential of marijuana on a wide range of ailments such as anxiety, sleep, hunger, multiple sclerosis, migraines, autism and pain.